TradingView
MarketMoversReport
Apr 13, 2022 3:57 PM

aTyr Pharma Announces FDA Orphan Drug Designation Long

NASDAQ:LIFE1D
aTyr Pharma, Inc.NASDAQ

Description

⋅
LIFE: aTyr Pharma, Inc.
2022-04-13 08:00:00
aTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis
Beyond Technical Analysis
More